
IBM has revealed it is to join forces with clinical laboratory service provider Quest Diagnostics in a bid to utilise …

Quest Diagnostics has begun selling a genetic test to uncover the risk of hereditary breast cancer, after the US Supreme …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

